Tg Therapeutics (TGTX) Research & Development (2011 - 2026)
Tg Therapeutics' Research & Development came in at $95.34 million for Q2 2026, up 200.0% from $31.78 million a year earlier and up 97.0% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Research & Development (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tg Therapeutics reported Research & Development of $225.8 million, up 84.8% year-over-year; for FY2025, it came in at $160.22 million, up 69.9% from FY2024.
- Research & Development carries a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
- Going back by year, Research & Development was $94.29 million in FY2024 (+23.8%), $76.19 million in FY2023 (-39.2%), $125.35 million in FY2022 (-43.7%) and $222.58 million in FY2021 (+34.2%).
- The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q2 2011.
- Year-over-year, Research & Development has increased for eight consecutive quarters, with growth averaging 72.0% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q2 2026 (growth of 200.0%), and the weakest in Q1 2023 (a decline of 67.0%).
- Business Quant data shows TGTX's Research & Development at $48.4 million (Q1 2026), $41.19 million (Q4 2025) and $40.88 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Tg Therapeutics | 7.56 Bn | 6.94 Bn | 199.14 Mn | 95.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.34 Mn |
| Mar 31, 2026 | 48.40 Mn |
| Dec 31, 2025 | 41.19 Mn |
| Sep 30, 2025 | 40.88 Mn |
| Jun 30, 2025 | 31.78 Mn |
| Mar 31, 2025 | 46.36 Mn |
| Dec 31, 2024 | 23.87 Mn |
| Sep 30, 2024 | 20.14 Mn |
| Jun 30, 2024 | 17.56 Mn |
| Mar 31, 2024 | 32.72 Mn |
| Dec 31, 2023 | 17.45 Mn |
| Sep 30, 2023 | 14.75 Mn |
| Jun 30, 2023 | 28.12 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 29.64 Mn |
| Sep 30, 2022 | 20.80 Mn |
| Jun 30, 2022 | 26.87 Mn |
| Mar 31, 2022 | 48.04 Mn |
| Dec 31, 2021 | 62.65 Mn |
| Sep 30, 2021 | 51.97 Mn |
API Access
Tg Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();